Press Releases May 19, 2026 04:31 PM

Golar LNG Limited: 2026 AGM Results Notification

Golar LNG Limited announces results and resolutions from the 2026 Annual General Meeting

By Sofia Navarro GLNG

Golar LNG Limited held its 2026 Annual General Meeting on May 19, 2026, where the audited financial statements for the year ended December 31, 2025, were presented. The meeting resulted in the re-election of all directors, the authorization to fill casual vacancies on the Board, reappointment of Ernst & Young LLP as auditors, and approval of director fees up to $2 million for 2026.

Golar LNG Limited: 2026 AGM Results Notification
GLNG

Key Points

  • All existing directors were re-elected to the Board of Directors.
  • Board authorized to fill vacancies as casual vacancies arise.
  • Ernst & Young LLP reappointed as independent auditors and director fees capped at $2 million for 2026.

Golar LNG Limited (the “Company”) advises that the 2026 Annual General Meeting of the Company was held on May 19, 2026 at 09:30 am (Bermuda time) at 2nd Floor, The S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda. The audited consolidated financial statements for the Company for the year ended December 31, 2025 were presented at the Meeting.

The following resolutions were passed:

  1. To set the maximum number of Directors to be not more than eight.
  2. To resolve that vacancies in the number of Directors be designated as casual vacancies and that the Board of Directors be authorised to fill such vacancies as and when it deems fit.
  3. To re-elect Tor Olav Trøim as a Director of the Company.
  4. To re-elect Daniel W. Rabun as a Director of the Company.
  5. To re-elect Carl E. Steen as a Director of the Company.
  6. To re-elect Niels G. Stolt-Nielsen as a Director of the Company.
  7. To re-elect Lori Wheeler Naess as a Director of the Company.
  8. To re-elect Benoît de la Fouchardiere as a Director of the Company.
  9. To re-elect Mi Hong Yoon as a Director of the Company.
  10. To re-elect Stephen Schaefer as a Director of the Company.
  11. To re-appoint Ernst & Young LLP of London, England as the Company’s independent auditors and to authorise the Directors to determine their remuneration.
  12. To approve director fees payable to the Company’s Board of Directors of a total amount of fees not to exceed US$2,000,000.00 for the year ending December 31, 2026.

Hamilton, Bermuda

May 19, 2026

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act


Risks

  • Potential uncertainty over future board composition despite authorization to fill vacancies, which could affect governance.
  • No mention of dividends or strategic changes may concern income-focused investors.
  • Limited new information or strategic updates could result in lack of market movement or investor enthusiasm.

More from Press Releases

ZOOZ Announces Expected Implementation of 1-for-20 Reverse Share Split May 19, 2026 Aura Announces its 2025 Sustainability Report May 19, 2026 Toll Brothers Reports FY 2026 Second Quarter Results May 19, 2026 Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 May 19, 2026 Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine) May 19, 2026